PubMed Health⌕ Search

PubMed · 12106041

Horizontal Interactions in Cat Striate Cortex: I. Anatomical Substrate and Postnatal Development.

Abstract

The system of tangential connections was studied in area 17 of normally reared (NR), binocularly deprived (BD) and dark-reared (DR) kittens and adult cats. Connections were labelled antero- and retrogradely by intracortical micro-injections of several fluorescent markers and horseradish peroxidase conjugated with wheat-germ agglutinin (WGA-HRP). In 5-day-old kittens tangential connections consist of homogeneously distributed fibres extending maximally over 2.7 mm. Around postnatal day (pnd) ten these connections start to express the patchy pattern characteristic of the adult. Retrogradely stained somata and anterogradely labelled terminals become organized in individual 300 to 350 microm wide clusters with a centre-to-centre spacing of about 500 microm. During the first three postnatal weeks the horizontal connections increase their span to up to 10.5 mm and the spacing between individual patches increases to about 700 microm. Over the following 4 weeks these projections become reduced in length and number. In adult NR cats, tangential connections span a distance of up to 3 mm and form a lattice of 200 - 500 microm wide clusters, which have an average centre-to-centre spacing of 1050 microm. Tangential connections originate and terminate in all cortical laminae except layer I and they are organized in register. The distances spanned are largest in supragranular, intermediate in infragranular and shortest in granular layers. In BD and DR cats older than 10 weeks, the length of intracortical tangential fibres becomes reduced to the same extent as in NR animals, but individual clusters are less numerous. The authors conclude that the lattice-like structure of lateral connections evolves independently of visual experience, and that the selectivity of interactions results from pruning of initially exuberant connections. It is suggested that this pruning process is dependent on activity and influenced by visual experience.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

H. J. Luhmann, W. Singer, L. Martínez-Millán. 1990. Horizontal Interactions in Cat Striate Cortex: I. Anatomical Substrate and Postnatal Development.. https://doi.org/10.1111/j.1460-9568.1990.tb00426.x

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Effectiveness of high-dose versus standard-dose influenza vaccines against hospitalisation according to frailty risk: a prespecified analysis of the randomised trial DANFLU-2.

BACKGROUND: Frailty is a major risk factor for influenza-related complications and can influence vaccine effectiveness. We aimed to assess the relative vaccine effectiveness (rVE) of high-dose (HD-IIV) versus standard-dose inactivated influenza vaccine (SD-IIV) in older adults aged 65 years or older according to frailty risk. METHODS: This study was a prespecified analysis of DANFLU-2, an open-label, individually randomised trial, conducted in Denmark during three consecutive influenza seasons (2022-23, 2023-24, and 2024-25). Adults aged 65 years or older were randomised (1:1) to the HD-IIV or SD-IIV group. The primary endpoint was hospitalisation for influenza or pneumonia. Frailty was defined according to the validated Hospital Frailty Risk Score (HFRS) based on ICD-10 codes within 10 years before randomisation. Participants were stratified into three HFRS categories, namely low (<5 points), intermediate (5-15 points), and high (>15 points) frailty risk. The rVE of HD-IIV versus SD-IIV against the primary endpoint was assessed across prespecified HFRS categories and treating HFRS as a continuous variable. Pearson's chi-square test was used to compare safety events across frailty risk groups and randomisation groups. FINDINGS: Among 332&#x2009;438 randomised participants (mean age 73&#xb7;7 years [SD 5&#xb7;8]; 161&#x2009;538 [48&#xb7;6%] were female), 276&#x2009;173 (83&#xb7;1%) had low frailty risk, 52&#x2009;395 (15&#xb7;8%) had intermediate frailty risk, and 3861 (1&#xb7;2%) had high frailty risk. The primary endpoint of hospitalisation for influenza or pneumonia occurred in 1424 (0&#xb7;5%) of 276&#x2009;173 participants with low frailty risk, 761 (1&#xb7;5%) of 52&#x2009;395 with intermediate frailty risk, and 163 (4&#xb7;2%) of 3861 with high frailty risk (relative risk [RR] for intermediate vs low frailty risk 2&#xb7;8 [95% CI 2&#xb7;6-3&#xb7;1]; RR for high vs low frailty risk 8&#xb7;2 [7&#xb7;0-9&#xb7;6]). HFRS as a continuous variable significantly modified the effect of HD-IIV versus SD-IIV against the primary endpoint with higher rVE estimates with increasing HFRS (pinteraction=0&#xb7;020). The rVE was 0&#xb7;2% (95% CI -10&#xb7;8 to 10&#xb7;2) among those with low frailty risk, 13&#xb7;1% (-0&#xb7;4 to 24&#xb7;8) among those with intermediate frailty risk, and 19&#xb7;9% (-10&#xb7;3 to 42&#xb7;1) among those with high frailty risk. No significant interaction was observed when HFRS was assessed according to the prespecified categorical frailty groups (pinteraction=0&#xb7;17). The proportion of participants with at least one serious adverse event increased across frailty risk groups (13&#x2009;366 [4&#xb7;8%] of 275&#x2009;795 for low frailty risk, 5475 [10&#xb7;5%] of 52&#x2009;315 for intermediate frailty risk, and 777 [20&#xb7;2%] of 3850 for high frailty risk; p<0&#xb7;0001), with similar proportions of serious adverse events in the HD-IIV and SD-IIV groups for each frailty risk group. INTERPRETATION: Among adults aged 65 years or older in Denmark, frailty risk might modify the effects of HD-IIV versus SD-IIV against hospitalisation for influenza or pneumonia, with higher rVE estimates with increasing frailty risk. These findings might support considering high-dose influenza vaccines for frail older adults. However, effect modification was not evident when frailty was assessed using prespecified categorical subgroups, and subgroup-specific estimates were imprecise, with 95% CIs crossing the null. These results should be considered exploratory, warranting further investigation. FUNDING: The DANFLU-2 trial was funded by Sanofi.

Journal Article↗